New genetic tests become standard of cancer care in BC

Vancouver – New multi-gene analysis panels are now available to oncologists and haematologists across British Columbia as provincial diagnostic tools, meaning a more personalized approach to treatment for thousands of eligible cancer patients. The OncoPanel and Myeloid Panel are clinical tests that can detect multiple different mutations in several genes simultaneously associated with solid or...

Why Biology Matters When it comes to Conquering Breast Cancer

Building on the world’s largest breast cancer study, BC Cancer Agency scientists map the relationship between cancer mutations and clinical outcomes in 2,433 women. Dr. Samuel Aparicio co-led a study with Dr. Carlos Caldas from Cancer Research UK and these teams have shown that what lies beneath the surface is critical as no two breast cancers are alike when you dig deeper. Building on a landmark...

Scientists map the spread of deadliest ovarian cancer

Vancouver – BC Cancer Agency researchers are providing critical insight into the invasive spread of the most malignant form of ovarian cancer in a landmark study, published today in Nature Genetics . This is a first in mapping two distinct patterns of ovarian cancer cell migration in high grade serous ovarian cancer. Dr. Sohrab Shah The discovery, led by Dr. Sohrab Shah, senior scientist at the...

Researchers Find Cause of Rare Gastric Cancer

VANCOUVER, B.C. – Today, families around the world have answers as to what’s causing a long history of stomach cancer. The international study involved BC Cancer Agency researchers and has discovered the genetic cause of a rare gastric condition that can lead to stomach cancer. The team, including Dr. David Huntsman, Distinguished Scientist at the BC Cancer Agency and Professor in the Departments...

A made-in-B.C. prostate cancer drug entering clinical trials

VANCOUVER, BC – A prostate cancer drug developed by researchers at the BC Cancer Agency and the University of British Columbia is entering human clinical trials. The drug is specifically designed to target and shut down metastatic castrate resistant prostate cancer (m-CRPC) when other treatments have failed. "Today represents a significant milestone as we witness the fruits of our labour in the...

BC Cancer Agency Researchers Develop Prognostic Test for Follicular Lymphoma

Vancouver – BC Cancer Agency researchers have published important findings with the power to predict patient response to existing treatment regimens. The results were released in The Lancet Oncology . The study, carried out in collaboration with scientists at the University Hospital of the Ludwig-Maximilians, University Munich, and collaborators at the Dana Farber Cancer Institute in Boston...

Significant childhood cancer discovery made by scientists at the BC Cancer Agency

Vancouver B.C. – Research published today by scientists at the BC Cancer Agency in Cancer Cell brings new hope for the treatment of high-risk childhood sarcomas – a type of cancer that has seen almost no treatment improvement in the last 20 years in spite of intense research efforts. Sarcomas are malignant – meaning they are cancerous – tumors of the connective tissues, including bones and...

Lifetime vigorous physical activity may lower risk of non-Hodgkin Lymphoma

A study from the Agency’s Center for Lymphoid Cancer shows that performing vigorous physical activity over your lifetime may lower your risk of non-Hodgkin lymphoma (NHL). The case-control study found that the most physically active participants had a lower risk for NHL than the least active participants, and that vigorous physical activity in particular was the most effective at lowering this...

BC Cancer Agency’s POG Program leads to a unique breakthrough in a patient’s treatment

Vancouver, B.C. – The Personalized Onco-Genomics (POG) Program at the BC Cancer Agency has identified a life-altering treatment option for a patient with advanced cancer. POG has given Trish Keating a new reason to hope as the genomic sequencing of her aggressive colorectal cancer identified a unique protein function at play. This critical detail pointed to an outside-of-the-box treatment option...

BC Cancer Foundation raises $6.5 million to secure first-in-Canada treatment technology at the BC Cancer Agency

Vancouver, BC – The BC Cancer Foundation has reached its $6.5-million fundraising target to purchase a state-of-the-art Vero™ machine to benefit cancer patients across B.C. The technologically-advanced radiotherapy system will be the first machine of its kind in Canada, as renovations get underway to accommodate the new treatment delivery system at the BC Cancer Agency Vancouver Centre. “We are...

Pages